1. Micrornas in prostate cancer: an overview
   Daniela Vanacore et al, 2017, Oncotarget CrossRef
2. MicroRNA-19b Promotes Nasopharyngeal Carcinoma More Sensitive to Cisplatin by Suppressing KRAS
   Yuan Zhang et al, 2018, Technology in Cancer Research & Treatment CrossRef
3. miR-19 Is a Potential Clinical Biomarker for Gastrointestinal Malignancy: A Systematic Review and Meta-analysis
   Xiaoxu Song et al, 2020, BioMed Research International CrossRef
4. MicroRNA-202 inhibits cell proliferation, migration and invasion of glioma by directly targeting metadherin
   Jinsheng Yang et al, 2017, Oncology Reports CrossRef
5. Exosomes co‐expressing AQP5‐targeting miRNAs and IL‐4 receptor‐binding peptide inhibit the migration of human breast cancer cells
   Eui‐Jung Park et al, 2020, The FASEB Journal CrossRef
6. MicroRNA-663 suppresses the proliferation and invasion of colorectal cancer cells by directly targeting FSCN1
   Shaojun Yu et al, 2017, Molecular Medicine Reports CrossRef
7. The Influence of Bcl-3 Expression on Cell Migration and Chemosensitivity of Gastric Cancer Cells via Regulating Hypoxia-Induced Protective Autophagy
   Lin Hu et al, 2020, Journal of Gastric Cancer CrossRef
8. MicroRNA‑19b inhibitors can attenuate the STAT3 signaling pathway in NPC C666‑1 cells
   Li‑Hui Bian et al, 2020, Molecular Medicine Reports CrossRef
9. Down‐regulation of microRNA‐19b in hormone receptor‐positive/HER2‐negative breast cancer
   Elham Maleki et al, 2018, APMIS CrossRef
10. Prognostic value of microRNAs in gastric cancer: a meta-analysis
    Yue Zhang et al, 2017, Oncotarget CrossRef
11. Link between miR-19b and the mTOR signaling pathway in cancer prognosis*
    Yanlin Feng et al, 2020, Oncology and Translational Medicine CrossRef
12. MicroRNA‐627‐5p inhibits the proliferation of hepatocellular carcinoma cells by targeting BCL3 transcription coactivator
    Jun Wang et al, 2020, Clinical and Experimental Pharmacology and Physiology CrossRef